# Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis

> **NCT01872026** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 14 (actual)

## Conditions studied

- Patients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis Therapy
- Pharmacodynamics of ASP7991
- Pharmacokinetics of ASP7991

## Interventions

- **DRUG:** ASP7991

## Key facts

- **NCT ID:** NCT01872026
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12-26
- **Primary completion:** 2013-06-26
- **Final completion:** 2013-06-26
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2024-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01872026

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01872026, "Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01872026. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*